PTGS2 and breast neoplasm: Because of our observation that COX-2 is an independent predictor of poor survival in ER-negative and HER2-positive breast tumors, we applied correlation and logistic regression analyses to examine the influence of both the tumor ER and HER2 status on the association between COX-2 and Akt pathway activation in 248 breast tumors.